Cancer Vaccines

Small Liposomes Boost Immunogenicity of Tumor Vaccines

Published in Vaccine Weekly, October 16th, 1995

Small-sized liposome adjuvants boost the immunogenicity of tumor vaccines derived from normally weakly immunogenic tumors toward more effective antimetastatic activity.

Previous research has shown that liposomes can effectively be used as adjuvants to stimulate humoral and cellular specific immune responses of tumor vaccines. O. Masso et al. submitted research to the 1994 International Symposium on Cancer Vaccines showing that the use of liposomes increases the immunogenicity of weakly immunogenic tumor vaccines.

S.F. Alino et al., from the University of Valencia, Spain, explored additional methods of improving liposome adjuvant methods of boosting...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-10-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry